IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer

Provides Significant and Broad Expertise in Clinical Trials, Regulatory Affairs

WEBSTER, Texas, May 24, 2010 – IDEV Technologies, Incorporated, (IDEV) an emerging leader in the
development and marketing of minimally invasive medical technologies, today
announced that veteran healthcare executive Dennis Donohoe, M.D., has been
named Chief Medical Officer. Dr. Donohoe reports directly to President and
Chief Executive Officer Christopher [...]

Mindray Recognised by Frost & Sullivan for Its Global Expansion and Acquisition Strategy

LONDON, May 24, 2010 – Based on its recent analysis of the patient monitoring market, Frost &
Sullivan recognises Mindray Medical International Limited (Mindray) with the
"2010 European Patient Monitoring Excellence in Globalisation Award."
Mindray, which maintains its global base for product development, engineering
and manufacturing in China, employs a vertically integrated operating model
that enables the company to [...]

Neusoft Medical Wins 2010 Frost & Sullivan New Product Innovation Award

SHENYANG, China, May 24, 2010 – Neusoft Medical Systems Co., Ltd. (Neusoft Medical), a wholly-owned
subsidiary of Neusoft Corporation (600718.SH), which is a leading IT
solutions & services provider in China, announced today that it received
"2010 Frost & Sullivan New Product Innovation Award" from Frost & Sullivan, a
world-renowned consulting and research corporation, for its remarkable
contribution to [...]

Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHP’s Summer Meeting, Tampa, June 6-8, 2010

BOZEN, Sud-Tirol, Italy, May 24, 2010 – Health Robotics today announced that on the heels of the recently
announced Health Robotics-McKesson exclusive partnership [
www.pr-inside.com/mckesson-expands-i-v-automation-portfolio-r1873650.h
tm] i.v.SOFT and i.v.STATION new product designs and Q&A sessions will be
held at the McKesson booth [701] of the American Society of Health-System
Pharmacists' Summer Meeting (ASHP) in Tampa, Florida, June 6-8, 2010.

[...]

Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting

CLEVELAND, Ohio, May 24, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is launching two new hands-on training systems- the Lap
Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will
be revealed for the first time at the AUA annual meeting in [...]

CID Vascular Sponsors Tech News & Trends at Euro PCR 2010

PARIS, May 26, 2010 – CID Vascular, a leader in interventional medicine, is sponsoring Tech
News & Trends at Euro PCR on May 26th in Paris. The two-hour session will
explore issues surrounding the complex decisions doctors must make when
implanting coronary stents in patients with conditions that affect blood
clotting.

Two live cases performed [...]

For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System

InspireMD is Also Proud to Announce That MGuard(TM) is Now Available With an Improved Delivery System

PARIS, May 26, 2010 – InspireMD, Ltd. announced today the next generation MGuard stent,
MGuard Prime(R), a net protective Cobalt Chromium stent system. MGuard
Prime(R) offers an advanced patented Cobalt Chromium design, superior
flexibility and excellent deliverability on top of the established [...]

Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System

Randomized Study of Nearly 3,000 Patients to Evaluate Company's Third-Generation Drug-Eluting Stent Technology

NATICK, Massachussetts, May 26, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced the
initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored
research (ISR) study designed to compare the performance of the PROMUS(R)
Element(TM) Everolimus-Eluting Coronary Stent System to the XIENCE PRIME(TM)
Everolimus-Eluting Coronary Stent [...]

Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States

Company Supplements Broad RNAi IP Portfolio and Strengthens Growing Position in Oncology

LONDON, May 26, 2010 – Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company")
announces the issuance of United States patent 7,723,316, titled Compositions
and Methods of RNAi Therapeutics For Treatment of Cancer and Other
Neovascularization Disease, by the United States Patent and Trademark Office
(USPTO). The [...]

First Coronary Stent on Drug Eluting Balloon Implanted

Innovation Improves Patient's Comfort and Reduces Procedure Cost Significantly

HELMOND, The Netherlands, May 25, 2010 – Blue Medical today announced a major step forward in its quest to improve
the quality of life of patients with cardiovascular disease, with the start
of the PIONEER trial, in which a new safe concept of stent-drug combination
is evaluated.
[...]

Cancer Detection at Your Fingertips: Bioholo-tomography Promises Enormous Growth Potential, According to Frost & Sullivan

LONDON, May 25, 2010 – As the potential cancer population increases, an effective long-term
solution for early cancer detection needs to be found. In some areas of the
world, cancer incidence is growing by 3 per cent per annum, and the cost of
cancer care is a ticking time bomb for global healthcare expenditure.

[...]

Philips Unveils Concepts of Future Living to Launch Livable Cities Awards

AMSTERDAM, May 25, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today gave a glimpse of
what our future living environments could be like with the unveiling of three
concepts – 'Healing Bed', 'Air Tree' and 'Soundbarrier'. All three concepts
aim to reconnect us with the natural environment, an increasingly rare
commodity in a today's urbanized world. [...]

Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers

CALGARY, Canada, May 25, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC,
NASDAQ:ONCY) today announced that it has opened enrollment in its Phase 3
trial examining REOLYSIN in combination with paclitaxel and carboplatin in
patients with platinum-refractory head and neck cancers. The Company had
previously received approval from the U.S. Food and Drug Administration (FDA)
under the Special Protocol Assessment [...]

Abbott’s Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves

Preliminary Results Also Show MitraClip Device Maintains Durability through Two Years in Patients Treated for Mitral Regurgitation

PARIS, May 25, 2010 – Abbott (NYSE: ABT) today announced new data from the landmark EVEREST II
(Endovascular Valve Edge-to-Edge REpair STudy) trial, which provide
additional details about the safety and clinical benefit of Abbott's
investigational MitraClip(R) system for the two [...]

New Data Reinforces Safety Profile of Abbott’s Market-Leading XIENCE V(R) Drug Eluting Stent

In XIENCE V USA Study, XIENCE V Demonstrates Low Blood Clot Rate at One Year in Real-World Patient Population

PARIS, May 25, 2010 – Two late-breaking clinical trials presented today at the EuroPCR 2010
conference reinforced the outstanding clinical data supporting Abbott's
market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System. In the
XIENCE V USA study of more [...]

NEVO(TM) Sirolimus-Eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data

NEVO(TM), Incorporating RES TECHNOLOGY(TM), Continues to Support Excellent Safety and Efficacy Outcomes vs. the Taxus(R) Liberte(R) According to Data Presented at EuroPCR 2010

PARIS, May 25, 2010 – At 12 months the NEVO(TM) Sirolimus-eluting Coronary Stent has continued
to demonstrate excellent safety and efficacy outcomes compared to Taxus(R)
Liberte(R) according to new data presented today from the [...]

Edwards SAPIEN Transcatheter Heart Valve Shows Positive One-Year Outcomes in Rigorous Post-Market Study

PARIS, May 25, 2010 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, today announced that
Martyn Thomas, M.D., reported that the Edwards SAPIEN transcatheter heart
valve demonstrated promising one-year mortality rates for high-risk patients,
many of whom were too sick to undergo traditional open-heart surgery. The
1,038-patient SOURCE Registry [...]

Spa & Resort/Medical Aesthetics Conference and Expo to Be Held September 28-29, 2010

Premier Event for Beauty Care, Skin Care and Spa Professionals Returns to New York

NEW YORK, May 25, 2010 – The Spa & Resort/Medical Aesthetics Conference and Expo
(www.spaandresortexpo.com) will return to New York this fall to educate,
inspire, and empower beauty, skin care, and wellness professionals. The
two-day trade show will take place from September 28-29, 2010 [...]

Abbott’s Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results

New Six-Month Data on Abbott's Bioresorbable Vascular Scaffold Reinforces Its Potential to Be the Next Revolution in Interventional Cardiology

PARIS, May 25, 2010 – Abbott (NYSE: ABT) today announced positive six-month results from the
first 45 patients enrolled in the second stage of the ABSORB trial, which was
presented during the Late-Breaking Clinical Trials session at the [...]

Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration With Oxygen Healthcare (O2h)

CAMBRIDGE, England, May 25, 2010 – Executives from Heptares Therapeutics (Welwyn Garden City, UK)
and O2h (Cambridge, UK) announced today an extension of the agreement under
which O2h provides multi-FTE -synthetic chemistry services to support
discovery programmes at Heptares.

Dr. Miles Congreve, Head of Chemistry said, "We are happy to have signed
this new contract [...]

First Major Survey of Multiple Sclerosis (MS) Nurses Highlights Significant Disparities in MS Nursing Across Europe

The Findings from MS-NEED (Multiple Sclerosis-Nurse Empowering EDucation): European Survey Highlights the Need to Define and Benchmark Healthcare Provision in MS Across Europe

BRUSSELS, May 26, 2010 – The first major survey of European Multiple Sclerosis (MS) nurses
revealed that nearly one in three nurses (31%) reported that standards of
MS care are not adequately maintained in [...]

Systech International and Videojet Brazil Partner to Meet Brazil’s Emerging Pharmaceutical Regulatory Requirements

Videojet Brazil will sell, install and support the Systech serialization solution, enabling life science manufacturers distributing product in Brazil to efficiently address track and trace initiatives

BRUSSELS, Belgium and SAO PAULO, Brazil, May 26, 2010 – Systech International, innovator of Packaging Execution Systems (PES)
(www.systech-tips.com/pes.php), and Videojet Brazil, a leading
supplier of encoding and marking solutions, today [...]

Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

NEWS HIGHLIGHTS

– Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges

– [...]

Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

NEWS HIGHLIGHTS

– Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges

– [...]

Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

NEWS HIGHLIGHTS

– Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges

– [...]

Trimega Sponsors Gwede Mantashe Event

CEO Adopts Role of 'Global South African'
LONDON, May 26, 2010 – UK-headquartered substance abuse testing company – Trimega Laboratories -
has been invited to sponsor an exclusive briefing event in London at which
the Secretary General of the African National Congress, Mr Gwede Mantashe,
will deliver a keynote speech.

The cocktail briefing is taking [...]

GAIN Calls on Leaders to Tackle the ‘Double Burden’ of Malnutrition in the MENA Region

DUBAI, UAE, May 26, 2010 – While wealthy Gulf States are grappling with a new epidemic of obesity,
millions across the Middle East and North Africa still suffer the hidden
hunger of under-nutrition.

This is the 'double-burden' of malnutrition in the MENA region and both
conditions are rooted in poor diet lacking in vitamins [...]

Abbott Announces European Launch of TREK(TM) Catheter System, Representing an Advancement in Balloon Technology

TREK Reflects a Leap in Balloon Design, with 10 Changes from 'Tip to Hub' for Improved Performance

PARIS, May 26, 2010 – Abbott (NYSE: ABT) today announced the European approval and launch of
its TREK(TM) Coronary Dilatation Catheter for the treatment of coronary
artery disease. The TREK system represents a new approach to balloon catheter
design, and provides [...]

Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom

Patent Covers Novel DP2 (CRTH2) Receptor Antagonists for the Treatment of Respiratory Disorders

SAN DIEGO, May 26, 2010 – Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual
Property Office has granted patent number GB2461629, titled, "HETEROALKYL
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS," which includes coverage of
Amira's AM461 DP2 receptor antagonist.
This is the second [...]

The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott’s Carotid Stent System and Surgery

Company Plans to File Application by End of Year Seeking an Expanded Indication to Treat Standard-Surgical-Risk Patient Population

ABBOTT PARK, Illinois, May 26, 2010 – Data from the CREST (Carotid Revascularization Endarterectomy vs.
Stenting Trial) study were published today in The New England Journal of
Medicine. In this trial, stenting and surgery had similar initial safety and
longer-term [...]

Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union

Given as an Injection Every Six Months, Prolia Reduced the Risk of Fractures in Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fractures

THOUSAND OAKS, California, May 28, 2010 – Amgen Inc. (Nasdaq: AMGN) today announced that the European Commission
(EC) has granted marketing authorization for Prolia(R) (denosumab) for the
treatment of osteoporosis in postmenopausal [...]

FirstAidWarehouse.co.uk Examines High Blood Pressure, or Hypertension, and Blood Pressure Monitors

YORK, England, May 28, 2010 – High blood pressure is a leading cause of deaths in the world. Apart from
millions with diagnosed hypertension, still many others are borderline
hypertensive. High blood pressure increases the risk of a person to develop
cardiovascular diseases, kidney problems, heart attack and even a stroke. One
of the major contributors to high [...]